Showing results (31-40 of 111) with videos related to
Sort By:
Pageof 12
Cancer|March 22, 2017
Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioningOrhan Kemal Yucel, Rima M Saliba, Gabriella Rondon, et al.Bone Marrow Transplantation|September 28, 2024
High activity of the new myeloablative regimen of gemcitabine/clofarabine/busulfan for allogeneic transplant for aggressive lymphomasJeremy Ramdial, Ruitao Lin, Peter F Thall, et al.British Journal of Haematology|March 8, 2016
Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantationRohtesh S Mehta, Rima M Saliba, Julianne Chen, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 7, 2013
Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantationLi Mei Poon, Amir Hamdi, Rima Saliba, et al.Current Research in Translational Medicine|January 27, 2019
HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplantArmin Ghobadi, Denái R Milton, Lohith Gowda, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 2, 2008
Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trialMuzaffar H Qazilbash, Rima M Saliba, Yago Nieto, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2012
Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcomeYago Nieto, Uday Popat, Paolo Anderlini, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 16, 2010
Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDSBorje S Andersson, Benigno C Valdez, Marcos de Lima, et al.Bone Marrow Transplantation|October 20, 2018
Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantationMithun Vinod Shah, Rima M Saliba, Gabriela Rondon, et al.Blood|January 27, 2009
Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphomaConstantine S Tam, Roland Bassett, Celina Ledesma, et al.Pageof 12